whatshot

TRDA   $18.74  3.82% Market Closed After Close 18.8 0.32%

Entrada Therapeutics Inc
show_chart Advanced Chart of TRDA
Last Events:

2023-08-06 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

2023-08-05 Trend Power changed from almost flat to .

2023-08-05 Trend changed from turning down to flat and down.

2023-08-04 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2023-08-04 Signal in RSI changed from bullish weakening to bearish. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-08-04 Signal in EMA100 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-04 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-04 Signal in EMA20 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 2
Target Price Mean 24.00
Mean unverified/preliminary 24.00 / 24.00
Target Price Low / High 20.00 / 28.00
Median / STD DEV 24.00 / 5.66
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy Sell None
rsi Buy None None
macd None None None
stoch None None None
ma20 None Sell Sell
ma50 None None None
ma100 ActivelyBuy Sell Buy
Candlestick PatternNov. 21, 2024 After Top Gap Down - pattern is a made up of five candlesticks. Pattern appears on a uptrend. The pattern begins with a white candlestick. The next two days are also white days. The third day gaps up and opens above the close of the second day. The fifth day is a strong black with a gap below the previous day’s close. Considered to be a bearish reversal pattern.
ISIN US29384C1080
ceo Mr. Dipal Doshi
Website https://www.entradatx.com
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.